May Lee, M. (2025) “Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy”, Dermatology Reports, 18(1). doi:10.4081/dr.2025.10315.